If you are 65 and older catching COVID-19 for the first time, or are experiencing a repeat infection, the message from infectious disease experts and geriatricians is clear: Seek treatment with antiviral therapy, preferably Paxlovid.

On January 1, 2023, the Inflation Reduction Act eliminated out-of-pocket costs for Medicare Part D beneficiaries who get vaccines recommended for adults by the Advisory Committee on Immunization Practices (ACIP). People with Medicare’s prescription drug coverage will pay no deductible and will not be responsible for any cost-sharing for ACIP-recommended vaccines, including shingles vaccine, Tdap and travel vaccines.

COVID-19 is challenging to explain, live through and communicate about. The materials on this webpage were created to help make communicating about COVID-19 a little easier. Choose from videos, posters, social stories and interactive activities to best meet your communication needs.

This is a tip sheet for providers on new CDC adult vaccine recommendations for Hepatitis B, Zoster (shingles), Pneumococcal, preferred flu vaccines for adults 65 and older, along with tools to help adults catch up on needed vaccinations.

Based on a presentation given on the topic, this video discusses the need to prepare for the flu season and to educate staff and patients about why it's important that they get their vaccines.

You Call the Shots is an interactive, web-based immunization training course. It consists of a series of modules that discuss vaccine-preventable diseases and explain the latest recommendations for vaccine use. This 15th module in the series discusses pneumococcal disease and its related vaccine.

The TMF Quality Innovation Network developed this document to assist health care professionals to increase patient safety by reducing C. diff rates and improving antibiotic stewardship in health care facilities serving high-risk fee-for-service Medicare beneficiaries.

TMF Quality Innovation Network diseñó este documento para ayudar a los profesionales de atención médica a aumentar la seguridad de los pacientes al reducir las tasas de infección con C. diff y mejorar el uso responsable de los antibióticos en las facilidades de atención médica que dan servicio a beneficiarios de pago por servicios de Medicare en alto riesgo.